\nZak Mir highlights some of the covid-19 players on the small-cap London market and gives an overview in this video charting update.
\n
\n\n\n\nAvacta Group (AVCT)
\n4d Pharma (DDDD)
\nFusion Antibodies (FAB)
\nGenedrive (GDR)
\nHemogenyx Pharmaceuticals (HEMO)
\nN4 Pharma (N4P)
\nNuformix (NFX)
\nNovacyt SA (NCYT)
\nOpen Orphan (ORPH)
\nOmega Diagnostics Group (ODX)
\nRemote Monitored Systems (RMS)
\nSynairgen (SNG)
\nTiziana Life Sciences (TILS)
\n
\nZakmir.com is a purely journalistic website \u2013 Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.
\n
\n\n\n(The opinions expressed here are those of the author, a columnist for Share Talk.)
\n
\nhttps://www.share-talk.com/covid-19-stock-special-bulletin-board-heroes-sunday-24th-january-2021/\n